EA201892257A1 - ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION - Google Patents

ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION

Info

Publication number
EA201892257A1
EA201892257A1 EA201892257A EA201892257A EA201892257A1 EA 201892257 A1 EA201892257 A1 EA 201892257A1 EA 201892257 A EA201892257 A EA 201892257A EA 201892257 A EA201892257 A EA 201892257A EA 201892257 A1 EA201892257 A1 EA 201892257A1
Authority
EA
Eurasian Patent Office
Prior art keywords
methods
antibodies
application
invention proposed
differentiation cluster
Prior art date
Application number
EA201892257A
Other languages
Russian (ru)
Inventor
Сиаочэн Чэнь
Марк С. Деннис
Аллен Дж. Джр. Эбенс
Тиму Т. Джунттила
Роберт Ф. Келли
Мэри А. Мэтиеу
Липин Л. Сунь
Original Assignee
Дженентек, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дженентек, Инк. filed Critical Дженентек, Инк.
Publication of EA201892257A1 publication Critical patent/EA201892257A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

В изобретении предложены антитела к кластеру дифференцировки 3 (CD3) и способы их применения.The invention proposed antibodies to differentiation cluster 3 (CD3) and methods for their use.

EA201892257A 2014-12-12 2014-12-17 ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION EA201892257A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201462091441P 2014-12-12 2014-12-12

Publications (1)

Publication Number Publication Date
EA201892257A1 true EA201892257A1 (en) 2019-03-29

Family

ID=65949991

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892257A EA201892257A1 (en) 2014-12-12 2014-12-17 ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION

Country Status (1)

Country Link
EA (1) EA201892257A1 (en)

Similar Documents

Publication Publication Date Title
EA201691266A1 (en) ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION
PH12018500711A1 (en) Anti-pd1 antibodies and methods of use
EA201790984A1 (en) ANTI-CD79B ANTIBODIES AND METHODS OF THEIR APPLICATION
EA201791029A1 (en) ANTIBODIES AGAINST INTERLEUKIN-33 AND THEIR APPLICATION
CL2017000545A1 (en) Anti-her2 and immunoconjugate antibodies
MX2020009461A (en) Anti-pvrig antibodies and methods of use.
PH12017500982A1 (en) Heterodimeric antibodies that bind cd3 and cd38
MX2021003704A (en) Heterodimeric antibodies that bind cd3 and tumor antigens.
EA201691610A8 (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF APPLICATION
MD3827845T2 (en) Subcutaneous formulations of anti-cd38 antibodies and their uses
MA40682B1 (en) Anti-ox40 antibodies and methods of use thereof
EP4335874A3 (en) Anti-hla-g antibodies and use thereof
MX2015012326A (en) Anti-crth2 antibodies and their use.
EA201600473A1 (en) HUMANIZED ANTIBODIES TO Tau (PS422) AND METHODS OF APPLICATION
MX2020010951A (en) Anti-hla-g antibodies and use thereof.
EA201890747A1 (en) METHODS OF TREATING INFLAMMATORY DISEASES
NZ730186A (en) Humanized anti-hepcidin antibodies and uses thereof
MA39355A1 (en) Anti-ox40 antibodies and methods of use thereof
EA201892257A1 (en) ANTI-CD3 ANTIBODIES AND METHODS OF APPLICATION
CL2018002006A1 (en) Anti-cd3 antibodies and methods of use (divisional application 201601556)
MY192384A (en) Anti-cd3 antibodies and methods of use
MA40663A1 (en) Heterodimeric Antibodies Binding to cd3 and cd38 Antigens